Novartis is getting creative with the pricing of its much-anticipated heart failure remedy, Entresto. A possible performance-based pricing system would come with a discount up front with bonus payments down the line if Entresto does what it is expected to. Learn more here. (Source: FiercePharma, 6/30/15)
You are here: / / What Will The Novartis Performance Pricing Look Like?